A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.
Clinical trial NCT07180771 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07180771
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-09-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.